Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

About 21 000 HIV patients have disappeared from Mpumalanga’s treatment system, yet officials remain unclear or deny the ...

Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on treatment since the end of February. But can it really be, especially since ...

The visit also served as an opportunity to explore how UNAIDS can support South Africa’s G20 Presidency and the country’s ...

The discontinuation of U.S. funding for HIV prevention under Trump's administration has severely impacted vulnerable ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

General, Winnie Byanyima, has called for a drastic and transparent reduction in the cost of lenacapavir, a twice-yearly ...

This is unacceptable in a country with one of the largest HIV treatment programmes in the world,"- Treatment Action ...